4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0001415889-25-018751
CHIEF FINANCIAL OFFICER acquired 6,617 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anderson Cynthia Lynn CHIEF FINANCIAL OFFICER | 2025-06-30 | Grant or award | +6,617 | $1.70 | $11,249 | 12,801 | D |
Loading xslF345X05/form4-07012025_090741.xml…